Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Daily News

Contentious Medical Device Tax May Soon Be Gone for Good

Yael L. Maxwell

December 20, 2019

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Todd Neale

November 27, 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

Presentation TCT 2019

Case 8 (From India): Expanding Indications of TAVR in India

Presenter: RAMA KRISHNA JANAPATI

September 25, 2019

$TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing$

Presentation TCT 2019

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Presenter: Janarthanan Sathananthan, MD

September 25, 2019

Presentation TCT 2019

Novel Access Routes for Structural Heart Intervention: Transcarotid, Transcaval, Transaxillary, Etc.

Presenter: Janet Wyman

September 25, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Todd Neale

July 19, 2019

Advertisement

Contentious Medical Device Tax May Soon Be Gone for Good

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

TCTMD’s Top 10 Most Popular Stories for November 2019

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Signal of Impaired Sapien XT Durability in Midterm Follow-up

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

Case 8 (From India): Expanding Indications of TAVR in India

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Novel Access Routes for Structural Heart Intervention: Transcarotid, Transcaval, Transaxillary, Etc.

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content